Cero Therapeutics Holdings, Stock Technical Analysis

CERO Stock   0.06  0.01  19.00%   
As of the 14th of December 2024, CERo Therapeutics shows the risk adjusted performance of 0.0496, and Mean Deviation of 12.24. CERo Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

CERo Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as CERo, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CERo
  
CERo Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
CERo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of CERo Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of CERo Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

CERo Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of CERo Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

CERo Therapeutics Trend Analysis

Use this graph to draw trend lines for CERo Therapeutics Holdings,. You can use it to identify possible trend reversals for CERo Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual CERo Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

CERo Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for CERo Therapeutics Holdings, applied against its price change over selected period. The best fit line has a slop of    , which means CERo Therapeutics Holdings, will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.08, which is the sum of squared deviations for the predicted CERo Therapeutics price change compared to its average price change.

About CERo Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of CERo Therapeutics Holdings, on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of CERo Therapeutics Holdings, based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on CERo Therapeutics price pattern first instead of the macroeconomic environment surrounding CERo Therapeutics. By analyzing CERo Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of CERo Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to CERo Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.

CERo Therapeutics December 14, 2024 Technical Indicators

Most technical analysis of CERo help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CERo from various momentum indicators to cycle indicators. When you analyze CERo charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

CERo Therapeutics December 14, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as CERo stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether CERo Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CERo Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cero Therapeutics Holdings, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cero Therapeutics Holdings, Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CERo Therapeutics Holdings,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CERo Therapeutics. If investors know CERo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CERo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.19)
Return On Assets
(0.45)
The market value of CERo Therapeutics is measured differently than its book value, which is the value of CERo that is recorded on the company's balance sheet. Investors also form their own opinion of CERo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CERo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CERo Therapeutics' market value can be influenced by many factors that don't directly affect CERo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CERo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CERo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CERo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.